Clinical Trial Update: ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

View source ↗

Summary

A completed clinical trial evaluating ATP expression in lymphocytes of individuals with multiple sclerosis using the ImmuKnow assay.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• ImmuKnow

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED